Therapy level of resistance represents a clinical problem for advanced non-small cell lung tumor (NSCLC), which even now remains to be an incurable disease. of CSCs. Furthermore, in various patient-derived tumors, level of resistance to cisplatin or even to epidermal development element receptor (EGFR) inhibitor treatment can be obtained through SLC25A1-mediated execution of mitochondrial activity… Continue reading Therapy level of resistance represents a clinical problem for advanced non-small